CXC-chemokine Ligand 9 (CXCL9) and Endothelial Activation and Stress Index (EASIX) for Prediction of Acute Graft Versus Host Disease

Summary

The prediction of severe acute GVHD before it occurs is of high importance for ensuing clinical decisions and overall success of allogeneic SCT. The key immunologic signatures associated with clinical outcomes after different graft versus host disease prophylaxis methods or peripheral blood stem cell transplant are largely unknown.

Eligibility

Age range

18–80 years

Sex

All

Healthy volunteers

Not specified

Interventions

• Diagnostic Test
  blood sample

  blood sample to check CXCL9 and EASIX at day 28 post stem cell transplant

Location